HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T L Cheng Selected Research

hydroxyaniline mustard

12/2001Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy.
3/2000Efficient clearance of poly(ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T L Cheng Research Topics

Disease

4Neoplasms (Cancer)
06/2009 - 03/2000
1Circulating Neoplastic Cells
01/2006
1Neoplasm Metastasis (Metastasis)
01/2006
1Lymphatic Metastasis
01/2006
1Stomach Neoplasms (Stomach Cancer)
01/2006
1Hepatocellular Carcinoma (Hepatoma)
12/2001
1Ascites
12/2001

Drug/Important Bio-Agent (IBA)

2hydroxyaniline mustardIBA
12/2001 - 03/2000
2Monoclonal AntibodiesIBA
12/2001 - 03/2000
2ProdrugsIBA
12/2001 - 03/2000
2GlucuronidesIBA
12/2001 - 03/2000
1Small Interfering RNA (siRNA)IBA
06/2009
1DNA (Deoxyribonucleic Acid)IBA
06/2009
1Keratin-19 (Keratin 19)IBA
01/2006
1Keratin-20 (Cytokeratin 20)IBA
01/2006
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2006
1Messenger RNA (mRNA)IBA
01/2006
1Carcinoembryonic AntigenIBA
01/2006
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2006
1GlucuronidaseIBA
12/2001
1Ethylene Glycol (Monoethylene Glycol)IBA
03/2000
1Immunoglobulin M (IgM)IBA
03/2000

Therapy/Procedure

2Therapeutics
06/2009 - 03/2000
1Transplantation
12/2001
1Intravenous Administration
03/2000
1Drug Therapy (Chemotherapy)
03/2000